Worsening of obesity and metabolic status yields similar molecular adaptations in human subcutaneous and visceral adipose tissue: decreased metabolism and increased immune response.

CONTEXT It is not known whether biological differences reported between sc adipose tissue (SAT) and visceral adipose tissue (VAT) depots underlie the pathogenicity of visceral fat. OBJECTIVE We compared SAT and VAT gene expression according to obesity, visceral fat accumulation, insulin resistance, and presence of the metabolic syndrome. DESIGN Subjects were assigned into four groups (lean, overweight, obese, and obese with metabolic syndrome). SETTING Subjects were recruited at a university hospital. PATIENTS Thirty-two women were included. MAIN OUTCOME MEASURES Anthropometric measurements, euglycemic-hyperinsulinemic clamps, blood analyses, and computed tomography scans were performed, and paired samples of SAT and VAT were obtained for DNA microarray-based gene expression profiling. RESULTS Considering the two fat depots together, 1125 genes were more and 1025 genes were less expressed in lean compared with metabolic syndrome subjects. Functional annotation clustering showed, from lean to metabolic syndrome subjects, progressive down-regulation of metabolic pathways including branched-chain amino acid, fatty acid, carbohydrate, and mitochondrial energy metabolism and up-regulation of immune response genes involved in toll-like receptor, TNF, nuclear factor-κB, and apoptosis pathways. Metabolism and immune response genes showed an opposite correlation with fat mass, fat distribution, or insulin resistance indices. These associations were similar in SAT and VAT, although about 1000 genes showed differential expression between SAT and VAT. CONCLUSIONS The increase in adiposity and the worsening of metabolic status are associated with a coordinated down-regulation of metabolism-related and up-regulation of immune response-related gene expression. Molecular adaptations in SAT prove as discriminating as those in VAT.

[1]  N. Calcutt Location, Location, Location? , 2013, Diabetes.

[2]  Kevin Y. Lee,et al.  Adipose Depots Possess Unique Developmental Gene Signatures , 2010, Obesity.

[3]  M. Kasuga,et al.  Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. , 2009, Cell metabolism.

[4]  T. Pers,et al.  Macrophages and Adipocytes in Human Obesity , 2009, Diabetes.

[5]  Svati H Shah,et al.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.

[6]  M. Blüher,et al.  Adipose tissue dysfunction in obesity. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[7]  M. Haluzík,et al.  The endocrine profile of subcutaneous and visceral adipose tissue of obese patients , 2008, Molecular and Cellular Endocrinology.

[8]  Yuji Yamamoto,et al.  Beneficial effects of subcutaneous fat transplantation on metabolism. , 2008, Cell metabolism.

[9]  D. James,et al.  Studies of regional adipose transplantation reveal a unique and beneficial interaction between subcutaneous adipose tissue and the intra-abdominal compartment , 2008, Diabetologia.

[10]  Leena Peltonen,et al.  Global Transcript Profiles of Fat in Monozygotic Twins Discordant for BMI: Pathways behind Acquired Obesity , 2008, PLoS medicine.

[11]  F. Karpe,et al.  Remodeling Phenotype of Human Subcutaneous Adipose Tissue Macrophages , 2008, Circulation.

[12]  K. Cianflone,et al.  Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissues⃞ Published, JLR Papers in Press, November 6, 2007. , 2008, Journal of Lipid Research.

[13]  A. Bouloumié,et al.  The role of endothelial cells in inflamed adipose tissue , 2007, Journal of internal medicine.

[14]  Yihai Cao Angiogenesis modulates adipogenesis and obesity. , 2007, The Journal of clinical investigation.

[15]  M. Stumvoll,et al.  Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. , 2007, The Journal of clinical endocrinology and metabolism.

[16]  Philipp E. Scherer,et al.  Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans , 2007, Diabetes.

[17]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[18]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[19]  A. Onat,et al.  Serum uric acid is a determinant of metabolic syndrome in a population-based study. , 2006, American journal of hypertension.

[20]  C. Kahn,et al.  Evidence for a role of developmental genes in the origin of obesity and body fat distribution. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Busse,et al.  Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin , 2006, Diabetologia.

[22]  T. Suganami,et al.  A Paracrine Loop Between Adipocytes and Macrophages Aggravates Inflammatory Changes: Role of Free Fatty Acids and Tumor Necrosis Factor α , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[23]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[24]  Jean-Daniel Zucker,et al.  Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. , 2005, Diabetes.

[25]  T. Hudson,et al.  A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. , 2004, Obesity research.

[26]  R. Busse,et al.  From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. , 2004, Diabetes.

[27]  L. Lönn,et al.  High expression of complement components in omental adipose tissue in obese men. , 2003, Obesity research.

[28]  F. Lönnqvist,et al.  Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. , 2002, Diabetes.

[29]  B. Wajchenberg Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. , 2000, Endocrine reviews.

[30]  S. O’Rahilly,et al.  The perils of portliness: causes and consequences of visceral adiposity. , 2000, Diabetes.

[31]  P. Eriksson,et al.  Leptin secretion from subcutaneous and visceral adipose tissue in women. , 1998, Diabetes.

[32]  P. Arner Not all fat is alike , 1998, The Lancet.

[33]  Johan Auwerx,et al.  Depot-Specific Differences in Adipose Tissue Gene Expression in Lean and Obese Subjects , 1998, Diabetes.

[34]  A Tremblay,et al.  Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. , 1990, Arteriosclerosis.

[35]  J. Seckl,et al.  11Β-Hydroxysteroid Dehydrogenase Type 1 and Obesity , 2008 .

[36]  M. Bissell Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene ExpressionMartinez FO, Gordon S, Locati M, et al (Univ of Milan, Italy; Univ of Oxford, England) J Immunol 177:7303–7311, 2006§ , 2008 .

[37]  N. Gerry,et al.  Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. , 2007, American journal of physiology. Endocrinology and metabolism.

[38]  R. Giorgino,et al.  Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells , 2007, Diabetologia.

[39]  B. Walker,et al.  11β-Hydroxysteroid Dehydrogenase Type 1 and Obesity , 2007 .